LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.
Loesche C, Picard D, Van Hoorick B, Schuhmann I, Jäger P, Klein K, Schuhler C, Thoma G, Markert C, Poller B, Zamurovic N, Weiss HM, Otto H, Fink M, Röhn TA.
Loesche C, et al. Among authors: schuhler c.
Clin Transl Sci. 2024 Feb;17(2):e13724. doi: 10.1111/cts.13724.
Clin Transl Sci. 2024.
PMID: 38407540
Free PMC article.
Clinical Trial.